Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 196 shares at $28.00 ($5K) on 2021-10-21, disclosed to the SEC on 2021-10-25.
Scheduled sale ($5k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |